Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Journal of Immunological Methods|October 13, 2018
Excessive outlier removal may result in cut points that are not suitable for immunogenicity assessmentsRobert J Kubiak, Jianchun Zhang, Pin Ren, et al.Journal of Biopharmaceutical Statistics|October 31, 2014
Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statisticSteven Novick, Yan Shen, Harry Yang, et al.COPD|October 12, 2013
Clinical trial simulation to assist in COPD trial planning and design with a biomarker-based diagnostic: when to pull the trigger?David L Gold, Michelle Dawson, Harry Yang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Lung cancer chemoprevention: a randomized, double-blind trial in Linxian, ChinaFarin Kamangar, You-Lin Qiao, Binbing Yu, et al.Journal of Biomolecular Screening|February 5, 2014
A New Bliss Independence Model to Analyze Drug Combination DataWei Zhao, Kris Sachsenmeier, Lanju Zhang, et al.Pediatric Transplantation|August 13, 2009
Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host diseaseJoel A Brochstein, Stephan Grupp, Harry Yang, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|August 14, 2012
Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of deathMarjorie A Rosenberg, Eric J Feuer, Binbing Yu, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2006
Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trialLeah B Sansbury, Andrew W Bergen, Kay L Wanke, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 19, 2003
Time and out-of-pocket costs associated with respiratory syncytial virus hospitalization of infantsShelah Leader, Harry Yang, John DeVincenzo, et al.PDA Journal of Pharmaceutical Science and Technology|March 15, 2017
Characterizing the Overall Derivatization of Conjugated Oligomeric ProteinsMichaela Wendeler, Wei Zhao, Christopher Thompson, et al.Pageof 12